B.Y. Yang et al. / Tetrahedron 67 (2011) 2427e2433
2433
with ethanol (3 mL) and deionized water (5 mL) sequentially. The
pre-conditioned cartridge was coated with 1 mL of each prepared
TBAB or K222 solution by passing through the cartridge. After
coating, cartridge was washed with deionized water (5 mL) to
remove the remaining solution. And captured 1 mL of [18F]fluoride,
which was produced from cyclotron. [18F]Fluoride captured car-
tridge was purged with nitrogen gas for 5 min (2.84 psi).
4.4. Determination of labeling efficiency
Labeling efficiency (%) was checked by TLC silica aluminum
sheet and radioactivity was scanner by using a radioTLC scanner.
The eluant was 95% (v/v) MeCN in water. Rf value of [18F]fluoride
was 0.1 and that of [18F]naphthol was 1.0.
Acknowledgements
This work was supported by the NRF (R0A-2008-000-20116-0),
the Converging Research Program funded by MEST (2010K001055),
and Korea Healthcare Technology R&D project funded by MHW
(A070001).
Supplementary data
Supplementary data associated with this article can be found in
MOL files and InChIKeys of the most important compounds
described in this article.
References and notes
1. Gambhir, S. S. Nat. Rev. Cancer 2002, 2, 683e693.
2. Choe, Y. S. Nucl. Med. Mol. Imaging 2004, 38, 121e130.
3. Kilbourn, M. R.; Hood, J. T.; Welch, M. J. Int. J. App. Radiat. Isot. 1984, 35,
599e602.
Fig. 7. Activation energy (Ea) graph of (a) 1 and (b) 3.
4. Steinbach, J.; Guenther, K.; Loesel, E.; Grunwald, G.; Mikecz, P.; Ando, L.; Sze-
lecsenyi, F.; Beyer, G. J. Appl. Radiat. Isot. 1990, 41, 753e756.
5. Toorongian, S. A.; Mulholland, G. K.; Jewett, D. M.; Bachelor, M. A.; Kilbourn, M.
R. Int. J. Rad. Appl. Instrum. B 1990, 17, 273e279.
6. Kim, H. W.; Jeong, J. M.; Lee, Y.-S.; Chi, D. Y.; Chung, K.-H.; Lee, D. S.; Chung, J.-
K.; Lee, M. C. Appl. Radiat. Isot. 2004, 61, 1241e1246.
Table 2
Activation energies calculated for 18F-Labeling of 1 and 3 in acetone, MeCN, and t-
BuOH
Solvent
Precursor
7. Hamacher, K.; Hirschfelder, T.; Coenen, H. H. Appl. Radiat. Isot. 2002, 56,
519e523.
1
3
8. McBride, W. J.; Sharkey, R. M.; Karacay, H.; D’Souza, C. A.; Rossi, E. A.; Laverman,
P.; Chang, C. H.; Boerman, O. C.; Goldenberg, D. M. J. Nucl. Med. 2009, 50,
991e998.
9. Laverman, P.; McBride, W. J.; Sharkey, R. M.; Eek, A.; Joosten, L.; Oyen, W. J.;
Goldenberg, D. M.; Boerman, O. C. J. Nucl. Med. 2010, 51, 454e461.
10. Navath, R. S.; Menjoge, A. R.; Wang, B.; Romero, R.; Kannan, S.; Kannan, R. M.
Biomacromolecules 2010, 11, 1544e1563.
Acetone
MeCN
t-BuOH
5.83
8.98
13.54
5.81
8.16
19.34
Values represent activation energies Ea (kcal/mol).
brine (2ꢀ400 mL), dried over anhydrous sodium sulfate (w5 g) for
15 min, and concentrated using a rotary vacuum evaporator at
50 ꢁC. The resulting oil was purified using a silica gel (w60 g) col-
umn chromatography (25:75 EtOAc/n-hexane; Rf¼0.5). Pure prod-
uct was obtained as a brown oil after drying using a rotary vacuum
11. Kang, C.; Yuan, X.; Li, F.; Pu, P.; Yu, S.; Shen, C.; Zhang, Z.; Zhang, Y. J. Biomed.
Mat. Res. Part A 2010, 93A, 585e594.
12. Lemaire, C. F.; Aerts, J.; Voccia, S.; Libert, L.; Mercier, F.; Goblet, D.; Plenevaux,
A.; Luxen, A. Angew. Chem., Int. Ed. 2010, 49, 3161e3164.
13. Aerts, J.; Voccia, S.; Lemaire, C.; Giacomelli, F.; Goblet, D.; Thonon, D.; Plene-
vaux, A.; Warnock, G.; Luxen, A. Tetrahedron Lett. 2010, 51, 64e66.
14. Whitesides, G. M. Nature 2006, 442, 368e373.
15. Lee, C.-C.; Sui, G.; Elizarov, A.; Shu, C. J.; Shin, Y.-S.; Dooley, A. N.; Huang, J.;
Daridon, A.; Wyatt, P.; Stout, D.; Kolb, H. C.; Witte, O. N.; Satyamurthy, N.;
Heath, J. R.; Phelps, M. E.; Quake, S. R.; Tseng, H.-R. Science 2005, 310,
1793e1796.
16. Gillies, J. M.; Prenant, C.; Chimon, G. N.; Smethurst, G. J.; Perrie, W.; Hamblett,
I.; Dekker, B.; Zweit, J. Appl. Radiat. Isot. 2006, 64, 325e332.
17. Steel, C. J.; O’Brien, A. T.; Luthra, S. K.; Brady, F. J. Labelled Compd. Radiopharm.
2007, 50, 308e311.
18. Audrain, H. Angew. Chem., Int. Ed. 2007, 46, 1772e1775.
19. Wester, H.-J.; Schoultz, B.; Hultsch, C.; Henriksen, G. Eur. J. Nucl. Med. Mol.
Imaging 2009, 36, 653e658.
evaporator at 45 ꢁC. Yield¼0.30 g, 1H NMR [300 MHz, CDCl3]:
d 7.83
(m, 1H), 7.80 (m, 1H), 7.61e7.63 (m, 1H), 7.52 (m, 1H), 7.50e7.51 (m,
1H), 7.44e7.47 (m, 1H), 4.38 (t, 2H), 3.65 (t, 2H), 3.21 (s, 3H), 2.18
(Quintet, 2H). 13C NMR [400 MHz, CDCl3]:
d 29.03, 37.05, 65.32,
66.27, 104.59, 121.70, 125.11, 125.24, 125.74, 126.28, 127.39, 134.34,
154.39. IR (KBr, cmꢂ1): 1359, 1190, 1171. MS (ESIþ) m/z calculated for
C14H16O4SNa: [MþNa]þ 303.0667, found 303.0591.
4.3. Pre-coating of solid-phase cartridges for CCE process
20. Tang, D.; Santschi, P. H. J. Chromatogr., A 2000, 883, 305e309.
21. Kim, D. W.; Jeong, H.-J.; Lim, S. T.; Sohn, M.-H. Nucl. Med. Mol. Imaging 2009, 43,
91e99.
22. Kim, D. W.; Jeong, H.-J.; Lim, S. T.; Sohn, M.-H.; Katzenellenbogen, J. A.; Chi, D. Y.
J. Org. Chem. 2008, 73, 957e962.
23. Kim, D. W.; Choe, Y. S.; Chi, D. Y. Nucl. Med. Biol. 2003, 30, 345e350.
24. El-Wetery, A. S.; El-Mohty, A. A.; Ayyoub, S.; Raieh, M. J. Labelled Compd. Ra-
diopharm. 1997, 39, 631e644.
Tetrabutylammonium bicarbonate (TBAB) solutionwas prepared
by purging CO2 gas into 40% tetrabutylammonium hydroxide for 6 h,
and then 40% TBAB 0.87 mL, deionized water 2.5 mL, and MeCN
17.4 mL were mixed. K2CO3/kryptofix 2.2.2 (K222) solution was
prepared by dissolving 181 mg of kryptofix 2.2.2 and 29 mg of K2CO3
in 10 mL deionized water. A C18 SepPak cartridge was prewashed
25. El-Tawoosy, M. J. Radioanal. Nucl. Chem. 2001, 249, 535e540.